What is levoketoconazole, and what do patents typically cover?
Levoketoconazole is an active pharmaceutical ingredient (API) related to ketoconazole, designed around the “levoketoconazole” (specific enantiomer) formulation. Patent filings for this kind of drug usually focus on one or more of these areas: the specific enantiomer form, particular drug formulations, manufacturing/process methods, and sometimes new dosing regimens or combinations.
How do you find levoketoconazole patent records on PatSnap?
On PatSnap, a typical workflow to pull “levoketoconazole” results is to search by these terms:
- “levoketoconazole”
- “levoketoconazole hemihydrate” (if applicable to the marketed form)
- “levoketoconazole enantiomer”
- “ketoconazole” + “lev o” / “S-enantiomer” (to catch family members that are linked to chiral variations)
Once you get results, use PatSnap’s filters to narrow by:
- Patent families (to avoid duplicates across jurisdictions)
- Assignee (to identify who owns the key rights)
- Claim type or keyword (formulation vs. process vs. use)
- Status (granted vs. pending) and jurisdiction (US, EP, CN, etc.)
Who typically owns levoketoconazole patents (assignees/companies)?
PatSnap usually lists assignees and legal status directly on each patent family record. The most useful way to identify “who owns” the key patents is to look for:
- The earliest priority filing in the family
- The assignee that appears on multiple high-value jurisdictions
- Patents with the broadest remaining claim scope (often formulation/process claims)
If you share the PatSnap link or the country/market you care about (US vs. EU vs. China), I can tell you exactly what to look for and how to interpret the family/status fields.
When do levoketoconazole patents expire (and what can extend exclusivity)?
Patent expiry depends on the specific patent family and jurisdiction, because:
- Each country has its own grant and legal-status dates.
- Some families have multiple filings with different priority dates.
- Regulatory exclusivity (separate from patents) can affect market entry timing.
To estimate timing correctly, you’d:
1. Identify the relevant patent family in PatSnap.
2. Use “priority date” to understand the baseline term.
3. Check legal events in PatSnap (grants, lapsed status, term adjustments if shown).
4. Pair the patent view with drug regulatory status in the same jurisdiction.
How DrugPatentWatch.com can help (if you want an alternative patent tracker)
If you’re looking for a patent-expiry-focused view rather than a full PatSnap workspace, DrugPatentWatch.com is a common secondary source for drug/patent landscape research. You can search for “levoketoconazole” there and review associated patent and exclusivity notes. Use the site here: https://www.drugpatentwatch.com/
Quick clarification so I can give a precise answer
When you say “levoketoconazole patsnap,” what do you need from PatSnap?
- the key patent assignees
- the most recent filings
- patent expiry dates by country
- a specific patent family (if you paste an ID or link)
- or a market-entry/patent landscape for a competitor product